HF
GOSS icon

HRT Financial’s Gossamer Bio GOSS Stock Holding History

HRT Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-956,879
Closed -$2.97M – 4146
2025
Q4 		$2.97M Buy
+956,879
New +$2.73M 0.01% 1046
2025
Q2 		– Sell
-389,452
Closed -$428K – 2977
2025
Q1 		$428K Buy
+389,452
New +$450K ﹤0.01% 1549
2024
Q2 		– Sell
-562,061
Closed -$663K – 2528
2024
Q1 		$663K Buy
562,061
+549,743
+4,463% +$605K ﹤0.01% 1107
2023
Q4 		$11K Buy
+12,318
New +$9.1K ﹤0.01% 2075
2023
Q2 		– Sell
-1,548,153
Closed -$1.95M – 2755
2023
Q1 		$1.95M Buy
+1,548,153
New +$2.96M 0.02% 608
2022
Q2 		– Sell
-10,175
Closed -$88K – 3213
2022
Q1 		$88K Sell
10,175
-1,456
-13% -$14K ﹤0.01% 2683
2021
Q4 		$131K Sell
11,631
-5,570
-32% -$66.2K ﹤0.01% 2685
2021
Q3 		$216K Buy
+17,201
New +$158K ﹤0.01% 2634
2021
Q2 		– Sell
-12,041
Closed -$111K – 3096
2021
Q1 		$111K Buy
+12,041
New +$121K ﹤0.01% 2450

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HRT Financial's GOSS Position: Q1 2026 in Review

HRT Financial sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 956,879 shares — an estimated $2.97M sold.

HRT Financial first reported a position in GOSS in Q1 2021 and held it in 9 quarters. The position peaked at $2.97M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • HRT Financial reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 956,879 Gossamer Bio shares in Q1 2026, an estimated $2.97M.
  • HRT Financial first reported a position in Gossamer Bio in Q1 2021 and held it in 9 quarters.
  • HRT Financial's Gossamer Bio position peaked at $2.97M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.